Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/147669
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Fawaz Assaad | |
dc.contributor.author | Hansdetlef Wassmann | |
dc.contributor.author | Maher Khodor | |
dc.date.accessioned | 2022-05-03T09:53:33Z | - |
dc.date.available | 2022-05-03T09:53:33Z | - |
dc.date.issued | 2019 | |
dc.identifier.isbn | 9781789857474 9781789857481 | |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/147669 | - |
dc.language.iso | eng | |
dc.publisher | IntechOpen | |
dc.relation.isbasedon | 10.5772/intechopen.72984 | |
dc.relation.uri | https://www.intechopen.com/books/pituitary-diseases | |
dc.rights.uri | CC BY-NC-ND (姓名標示-非商業性-禁止改作) | |
dc.source | DOAB | |
dc.subject.classification | Diseases of the endocrine glands. Clinical endocrinology | |
dc.subject.other | thrombin inhibition | |
dc.subject.other | LMWH | |
dc.subject.other | antithrombin | |
dc.subject.other | heparin oligosaccharides | |
dc.subject.other | ternary complex | |
dc.subject.other | heparin | |
dc.subject.other | hepcidin | |
dc.subject.other | iron homeostasis | |
dc.subject.other | anemia | |
dc.subject.other | heparin-induced thrombocytopenia | |
dc.subject.other | diagnosis | |
dc.subject.other | functional assay | |
dc.subject.other | platelets | |
dc.subject.other | heparin | |
dc.subject.other | heparan sulphate | |
dc.subject.other | TGF-? | |
dc.subject.other | bone morphogenetic protein (BMP) | |
dc.subject.other | growth and differentiation factor (GDF) | |
dc.subject.other | GDNF | |
dc.subject.other | BMP antagonists | |
dc.subject.other | noggin | |
dc.subject.other | sclerostin | |
dc.subject.other | gremlin | |
dc.subject.other | heparin | |
dc.subject.other | enoxaparin | |
dc.subject.other | subarachnoid hemorrhage | |
dc.subject.other | edema | |
dc.subject.other | brain injury | |
dc.subject.other | inflammation | |
dc.subject.other | cisplatin | |
dc.subject.other | low molecular weight heparin (LMWH) | |
dc.subject.other | ovarian cancer | |
dc.subject.other | resistance | |
dc.subject.other | heparin | |
dc.subject.other | glycosaminoglycans | |
dc.subject.other | chondroitin sulfate | |
dc.subject.other | perylene diimide dyes | |
dc.subject.other | dermatan sulfate | |
dc.subject.other | fluorescent probe | |
dc.subject.other | Heparin Red | |
dc.subject.other | assay | |
dc.subject.other | dermatan sulfate | |
dc.subject.other | human plasma | |
dc.subject.other | heparin | |
dc.subject.other | alginate | |
dc.subject.other | sulfated alginate | |
dc.subject.other | biomaterials | |
dc.subject.other | heparin | |
dc.subject.other | heparan sulfate | |
dc.subject.other | serglycin | |
dc.subject.other | proteoglycan | |
dc.subject.other | recombinant expression | |
dc.subject.other | bioreactor | |
dc.subject.other | theranostics | |
dc.subject.other | solid lipid nanoparticles | |
dc.subject.other | iron oxide nanoparticles | |
dc.subject.other | heparin coating | |
dc.subject.other | intestinal lymphatic absorption | |
dc.subject.other | heparin | |
dc.subject.other | heparin process | |
dc.subject.other | manufacturing methods | |
dc.subject.other | industrial | |
dc.subject.other | super paramagnetic iron oxide nanoparticles (SPION) | |
dc.subject.other | hyaluronic acid (HA) | |
dc.subject.other | bovine serum albumin (BSA) | |
dc.subject.other | Fe3O4·DA-BSA/HA | |
dc.subject.other | paclitaxel (PTX) | |
dc.subject.other | magnetic resonance imaging (MRI) | |
dc.subject.other | low-molecular-weight heparin | |
dc.subject.other | dalteparin | |
dc.subject.other | NMR | |
dc.subject.other | LC-MS | |
dc.subject.other | affinity chromatography | |
dc.subject.other | danaparoid sodium | |
dc.subject.other | low molecular weight glycosaminoglycans | |
dc.subject.other | orthogonal multi-analytical methods | |
dc.subject.other | sequence and compositional investigations | |
dc.subject.other | component quantitative analysis | |
dc.subject.other | heparin | |
dc.subject.other | crude heparin | |
dc.subject.other | NMR | |
dc.subject.other | quantitative NMR | |
dc.subject.other | PCA | |
dc.subject.other | chemometric | |
dc.subject.other | HSQC | |
dc.subject.other | bovine heparin | |
dc.subject.other | porcine heparin | |
dc.subject.other | molecular weight | |
dc.subject.other | size exclusion chromatography | |
dc.subject.other | pharmacopeia | |
dc.subject.other | Fondaparinux sodium | |
dc.subject.other | extended physicochemical characterization | |
dc.subject.other | qNMR | |
dc.subject.other | single crystal X-ray structure | |
dc.subject.other | reference standard | |
dc.subject.other | iduronic acid conformation | |
dc.subject.other | Arixtra® | |
dc.subject.other | n/a | |
dc.subject.other | n/a | |
dc.subject.other | n/a | |
dc.title | Pituitary Diseases | |
dc.type | 電子教科書 | |
dc.classification | 醫學類 | |
Theme: | 教科書-醫學類 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.